Bulletin
Investor Alert

Lipocine Inc.

NAS: LPCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 26, 2022, 7:57 p.m.

/zigman2/quotes/202742746/composite

$

0.44

Change

-0.0048 -1.08%

Volume

Volume 9,597

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Today's close

$ 0.50

$ 0.44

Change

-0.05 -10.41%

Day low

Day high

$0.43

$0.49

Open

52 week low

52 week high

$0.43

$1.89

Open

Morgan R. Brown

Transactions

Date Shares Transaction Value
12/16/2020 8,437   Disposition at $1.35 per share. 11,390
12/16/2020 28,125   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2020 70,754   Derivative/Non-derivative trans. at $0 per share. 0
12/04/2020 17,250   Disposition at $1.57 per share. 27,083
12/04/2020 57,500   Derivative/Non-derivative trans. at $0 per share. 0
12/04/2019 17,250   Disposition at $0.41 per share. 7,073
12/04/2019 57,500   Derivative/Non-derivative trans. at $0 per share. 0
12/29/2017 2,813   Disposition at $3.47 per share. 9,762
12/29/2017 9,375   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Mahesh V. Patel
Chairman, President, Chief Executive Officer & CFO
Dr. Anthony DelConte
Chief Medical Director
Dr. Nachiappan Chidambaram
Vice President-Product Development
Mr. John W. Higuchi
Director
Ms. Krista Fogarty
Chief Accounting Officer
Mr. Hans Vitzthum
Head-Investors Relation Contact
Dr. Jill M. Jene
Independent Director
Dr. Spyros Papapetropoulos
Independent Director
Dr. Richard Dana Ono
Independent Director
Mr. Jeffrey Arvin Fink
Independent Director
Link to MarketWatch's Slice.